NeoChats Anne

Series 8 | Episode 3: Infectious Diseases in the NICU – Preventing & Managing Congenital Neonatal STBBI Infection Risks
GUEST:
Ari Bitnun, MD, MSc, FRCPC, FIDSA
Division of Infectious Diseases
Hospital for Sick Children
Professor, Department of Pediatrics
Toronto, ON 
Biography: Dr. Ari Bitnun is a Professor in the Department of Pediatrics, University of Toronto and a staff physician in the Division of Infectious Diseases, Hospital for Sick Children. His main areas of interest are pediatric HIV, congenital infections and infections of the central nervous system. He is the director of the Family Centred HIV Clinic and the Congenital and Perinatal Infection Clinic at SickKids.

This podcast is sponsored by Sanofi

Series 8 | Episode 2: Infectious Diseases in the NICU – Congenital CMV 
 GUEST:
Jeffrey Pernica, MSc, MD, FRCPC, DTMH
Head of the Division of Infectious Disease,
Associate Professor in the Department of Pediatrics, 
McMaster University, Hamilton, ON
Biography: Dr. Jeffrey Pernica is the Head of the Division of Infectious Disease and Associate Professor in the Department of Pediatrics at McMaster University. His clinical interests, aside from infectious disease in general, include tropical medicine (he is a member of the Canadian Committee to Advise on Tropical Medicine and Travel), immunization (he is the director of the Special Immunization Clinic at McMaster Children’s Hospital), and congenital CMV (he is the regional lead for the Ontario CMV newborn screening program).

His research interests relate to the optimization of the diagnosis and treatment of respiratory infections, enteric infections, and sepsis, both for children living in resource-rich as well as resource-limited settings. He has long been involved in global child health and global health research, having worked on retrospective cohort studies, prospective cohort studies, and randomized trials in Botswana and other low- and middle-income countries.

He was the recipient of a Hamilton Health Sciences Early Career Award and an IDWeek 2020 Investigator Award. He has received research funding as PI from Hamilton Health Sciences, the Physicians’ Services Incorporated Foundation, the Hamilton Academic Health Sciences Organization Innovation Fund, and Grand Challenges Canada.

 This podcast is sponsored by Sanofi

Series 8 | Episode 1: Infectious Diseases in the NICU - RSV
 
GUEST:
Joanne M. Langley, MD, MSc, FRCPC
Professor of Pediatrics and Community Health and Epidemiology
GSK-CIHR Chair in Pediatric Vaccinology, Dalhousie University
Head, Division of Pediatric Infectious Diseases, IWK Health
Halifax, Nova Scotia
Biography: Dr. Langley is a pediatric infectious disease physician at the IWK Health Centre in Halifax, a professor in the Faculty of Medicine at Dalhousie University, and Director of the Evaluation Group at the Canadian Center for Vaccinology. She conducts studies on the prevention of infectious diseases using vaccines, from phase 1 (first in humans) through to efficacy trials (phase 3) and post-marketing studies of how well vaccines work when they are used in immunization programs (phase 4). These studies are done with collaborators in public health, industry, universities, and non-governmental organizations. 
Dr. Langley has a particular interest in prevention of respiratory infections such as Respiratory Syncytial Virus and influenza. Her work also focuses on vaccine policy and evidence-based decision making in immunization programs. She is a member of the COVID-19 Science Expert Panel, the Expert Group on Health Systems of the Chief Science Advisor of Canada, a former member of the Canadian Task Force on Preventive Health Care and Canada’s National Advisory Committee on Immunization (Chair, 2007-2011), and serves as an advisor on several immunization decision making expert groups. She is an active investigator in the Canadian Immunization Research Network and leads its Clinical Trials Network (CTN).
This podcast is sponsored by Sanofi

CANN 2023 NATIONAL CONFERENCE

October 1 & 2, 2023 | MaRS Centre | Toronto

Embracing the theme "Neonatal Nursing: Our Path Forward Together", this two-day conference will feature an inspiring and dynamic line-up of speakers, sessions hosted in partnership with the Canadian Premature Babies Foundation, poster boards, exhibits and networking events. 
 REGISTER EARLY TO TAKE ADVANTAGE OF THE GREAT EARLY BIRD RATE

 CANN MEMBER – $349
 NON-MEMBER – $429 | STUDENT – $99 (Includes a 1-year CANN membership)

Registration rates include attendance at all conference sessions, continental breakfast on Monday, lunch on Sunday and Monday, refreshment breaks and the Welcome Reception on Sunday.

REGISTER NOW   

Series 7 | Episode 4: RSV Eligibility and Programs

GUEST:
Aaron Chiu, MD, FRCPC, FAAP, MBA, ICD.D
Associate Dean - Quality Improvement and Accreditation
Director - Manitoba RSV Prophylaxis Program
Associate Professor (Neonatology), Department of Pediatrics
Max Rady College of Medicine, Rady Faculty of Health Sciences
Biography: Dr. Aaron Chiu is the associate dean, Quality Improvement and Accreditation, and associate professor of pediatrics, and obstetrics and gynecology took on the associate dean role in 2016. Dr. Chiu joined University of Manitoba as a faculty member in 1998 and practices neonatology at the HSC Winnipeg Women’s Hospital Neonatal Intensive Care Unit and at the St. Boniface Hospital Neonatal Intensive Care Unit. He is the chair of the Manitoba RSV Immunoprophylaxis Program Committee, and deputy chair of the Committee on Accreditation of Canadian Medical Schools. He has held the position of chair of neonatal-perinatal medicine at the Royal College of Physicians and Surgeons of Canada, was a board member of MD Financial Holdings and was president of Doctors Manitoba (2017-18). Dr. Chiu is a graduate of the University of Toronto, where he undertook his undergraduate education and attended medical school. He completed his residency and a neonatal-perinatal fellowship at the University of Ottawa. In 2012, he earned his masters of business administration from UM’s Asper School of Business and was a Gold Medal recipient."

This podcast is sponsored by AstraZeneca Canada

NeoChats - Series 7 | Episode 3: Epidemiology of RSV

GUEST:
Jesse Papenburg, MD, MSc, FRCPC
Pediatric Infectious Diseases Specialist and Medical Microbiologist
Montreal Children’s Hospital, McGill University Health Centre
Montreal, QC

Biography: Dr. Jesse Papenburg practices Pediatric Infectious Diseases and Medical Microbiology at the Montreal Children’s Hospital of the McGill University Health Centre. Dr. Papenburg’s research is on the epidemiology of viral respiratory infections, with a focus on diagnostics to improve treatment and outcomes. He actively contributes to national and provincial guidelines on RSV immunoprophylaxis, influenza antiviral treatment and SARS-CoV-2 diagnostics and treatment. Since 2019, Dr. Papenburg is a voting member of the National Advisory Committee on Immunization, developing vaccine recommendations in Canada.

This podcast is sponsored by AstraZeneca Canada